Rufinamide: a guide to its use in Lennox-Gastaut syndrome

Author：

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.7, 2010-07, pp. : 6-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rufinamide: A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome

By McCormack Paul L.

PharmacoEconomics, Vol. 30, Iss. 3, 2012-03 ,pp. : 247-256

Adis International

Access to resources Recommend Favorite

Rufinamide for the treatment of Lennox––Gastaut syndrome

By Besag Frank MC

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 801-806

Informa Healthcare

Access to resources Recommend Favorite

Rufinamide for Pediatric Patients with Lennox-Gastaut Syndrome: A Comprehensive Overview

By >

Pediatric Drugs, Vol. 13, Iss. 2, 2011-04 ,pp. : 97-106

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK

By Benedict Ágnes

PharmacoEconomics, Vol. 28, Iss. 3, 2010-03 ,pp. : 185-199

Adis International

Access to resources Recommend Favorite

Rufinamide improves outlook in poorly controlled Lennox-Gastaut

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite